<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35115665</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5470</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Genes and immunity</Title><ISOAbbreviation>Genes Immun</ISOAbbreviation></Journal><ArticleTitle>Ligand-of-Numb protein X1 controls the coxsackievirus B3-induced myocarditis via regulating the stability of coxsackievirus and adenovirus receptor.</ArticleTitle><Pagination><StartPage>42</StartPage><EndPage>46</EndPage><MedlinePgn>42-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41435-022-00163-x</ELocationID><Abstract><AbstractText>Group B coxsackieviruses (CVBs) are the main cause of virus-induced myocarditis. CVBs use coxsackievirus and adenovirus receptor (CAR) for infection and targeting CAR has been shown to ameliorate CVBs-induced myocarditis. Ligand-of-Numb protein X1 (LNX1) is an E3 ubiquitin ligase that was shown to interact with CAR. However, the precise effect of LNX1 on CAR and the roles of LNX1 on CVBs-induced myocarditis remain unknown. In the present study, we generated mice deficient in LNX1 in the heart and evaluated the symptoms of myocarditis after CVB3 infection. We also monitored the expression and ubiquitination of CAR in LNX1-deficient cardiomyocytes after CVBs infection. We found that CVBs infection decreased CAR expression while promoted the expression of LNX1. Mice with deficiency of LNX1 in the heart had normal myocardial development while had deteriorated myocarditis symptoms after CVB3 infection. In LNX1-deficient cardiomyocytes, decreased ubiquitination of CAR and upregulation of CAR were observed after CVB3 infection. In summary, LNX1 controls CVB3-induced myocarditis by regulating the expression of CAR.</AbstractText><CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, XI'AN International Medical Center Hospital, No. 777, Xitai Road, Chang'an District, Xi'an, 710100, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Changying</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, XI'AN International Medical Center Hospital, No. 777, Xitai Road, Chang'an District, Xi'an, 710100, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Jinjuan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, XI'AN International Medical Center Hospital, No. 777, Xitai Road, Chang'an District, Xi'an, 710100, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Zhenyin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, XI'AN International Medical Center Hospital, No. 777, Xitai Road, Chang'an District, Xi'an, 710100, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaoni</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, XI'AN International Medical Center Hospital, No. 777, Xitai Road, Chang'an District, Xi'an, 710100, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Chuang</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2313-2538</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, XI'AN International Medical Center Hospital, No. 777, Xitai Road, Chang'an District, Xi'an, 710100, Shaanxi, China. Sunchuang2020@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genes Immun</MedlineTA><NlmUniqueID>100953417</NlmUniqueID><ISSNLinking>1466-4879</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C106293">Numb protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C085301">adenovirus receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C111865">Lnx1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35115665</ArticleId><ArticleId IdType="doi">10.1038/s41435-022-00163-x</ArticleId><ArticleId IdType="pii">10.1038/s41435-022-00163-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113:593–5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.589663</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010;52:274–88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2009.11.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466–72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(03)00648-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Maginnis MS. Virus-receptor interactions: the key to cellular invasion. J Mol Biol. 2018;430:2590–611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.06.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallewaard NL, Zhang L, Chen JW, Guttenberg M, Sanchez MD, Bergelson JM. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe. 2009;6:91–8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.05.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Excoffon K. The coxsackievirus and adenovirus receptor: virological and biological beauty. FEBS Lett. 2020;594:1828–37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13794</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell. 2006;124:119–31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.10.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zautner AE, Korner U, Henke A, Badorff C, Schmidtke M. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol. 2003;77:10071–7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.18.10071-10077.2003</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie J, McGill MA, Dermer M, Dho SE, Wolting CD, McGlade CJ. LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin-dependent degradation. EMBO J. 2002;21:93–102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/21.1.93</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollerbrant K, Raschperger E, Mirza M, Engstrom U, Philipson L, Ljungdahl PO, et al. The Coxsackievirus and adenovirus receptor (CAR) forms a complex with the PDZ domain-containing protein ligand-of-numb protein-X (LNX). J Biol Chem. 2003;278:7439–44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M205927200</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang NH, Song LB, Wu XJ, Li RP, Zeng MS, Zhu XF, et al. Proteasome inhibitor MG-132 modifies coxsackie and adenovirus receptor expression in colon cancer cell line lovo. Cell Cycle. 2008;7:925–33.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.7.7.5621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei L, Bandola-Simon J, Roche PA. Ubiquitin-conjugating enzyme E2 D1 (Ube2D1) mediates lysine-independent ubiquitination of the E3 ubiquitin ligase March-I. J Biol Chem. 2018;293:3904–12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.001322</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopoulos G, Triantafilou K, Triantafilou M. Coxsackie B viruses use multiple receptors to infect human cardiac cells. J Med Virol. 2004;74:291–9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20184</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkert S, Westermann D, Wang X, Klingel K, Dörner A, Savvatis K, et al. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor. Circulation. 2009;120:2358–66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.845339</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkert S, Dieringer B, Klopfleisch R, Savvatis K, Van Linthout S, Pryshliak M, et al. Early treatment of coxsackievirus B3-infected animals with soluble coxsackievirus-adenovirus receptor inhibits development of chronic coxsackievirus B3 cardiomyopathy. Circ Heart Fail. 2019;12:e005250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.119.005250</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998;8:397–403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(98)01346-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Callis J. The ubiquitination machinery of the ubiquitin system. Arabidopsis Book. 2014;12:e0174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1199/tab.0174</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503–33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.70.1.503</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzger MB, Pruneda JN, Klevit RE, Weissman AM. RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim Biophys Acta. 2014;1843:47–60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2013.05.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza M, Hreinsson J, Strand ML, Hovatta O, Söder O, Philipson L, et al. Coxsackievirus and adenovirus receptor (CAR) is expressed in male germ cells and forms a complex with the differentiation factor JAM-C in mouse testis. Exp Cell Res. 2006;312:817–30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2005.11.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu B, Xue W, Zhang H, Zhang R, Feldman K, Zhao Q, et al. MicroRNA-325-3p facilitates immune escape of Mycobacterium tuberculosis through targeting LNX1 via NEK6 accumulation to promote anti-apoptotic STAT3 signaling. mBio. 2020;11:e00557–20.</Citation><ArticleIdList><ArticleId IdType="pubmed">32487755</ArticleId><ArticleId IdType="pmc">7267881</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>